Skip to main content
. 1998 Oct;153(4):1229–1237. doi: 10.1016/S0002-9440(10)65667-2

Table 2.

IL-10 and EBER mRNA Expression in Anaplastic T-Cell Lymphomas: Correlation with Cytotoxic Protein Expression by Immunohistochemistry

Cases Age/Sex Histological variant (Kiel/REAL) Site of biopsy Other sites of involvement (clinical stage) IL-10 mRNA expression (positive cells/mm2) TIA-1 Granzyme EBER EMA ALK1 Outcome
29 66 /M ALCL T Node NA 37.5 NA
30 20 /F ALCL T Node IV 1.4* ++ + + + CR, AWD (24 months)
31 40 /M ALCL T Node III 98.8 ++ ++ DOD
32 40 /M ALCL T Node IV 105/8.3 +++ +++ + + CR, AWD (36 months)
33 20 /F ALCL T Node II 80.9 +++ +++ + + NA
34 37 /M ALCL T Node I 9 ++ + + + CR
35 82 /F ALCL null Node IV 13.3 +++ + DOD
36 38 /M ALCL null Node IV 87.5/5.5 + ND DOD, 2 weeks
37 16 /F ALCL null Node NA 133.3 + +++ ND + DOD
38 21 /M ALCL null Node II 46.1 ++ +++ ND CR, AWD (16 months)
39 11 /M ALCL null Node I 119.4 ND ND + + Relapse, 2nd CR Alive (48 months)

For IL-10, the number of positive cells was estimated per mm 2 of tissue sections. For TIA-1, granzyme B, and EBER, the results were expressed as in Table 1 .

Abbreviations: REAL, Revised European-American Lymphoma classification; NA, not available; ND, not done; M, male; F, female; AWD, alive without disease; DOD, dead of disease; and CR, complete remission.

*This lymphohistiocytic variant showed only scattered positive cells that could correspond to scattered neoplastic cells.

Two patterns of expression were observed in the same tissue section; counts were done in two distinct areas of the tissue.